192 related articles for article (PubMed ID: 6342356)
1. Enzyme-induced asparagine and glutamine depletion and immune system function.
Kafkewitz D; Bendich A
Am J Clin Nutr; 1983 Jun; 37(6):1025-30. PubMed ID: 6342356
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of blastogenesis by native and polyethylene glycol-modified asparaginases from Escherichia coli and Vibrio succinogenes.
Bendich A; Kafkewitz D; Abuchowski A; Davis FF
Immunol Commun; 1983; 12(3):273-84. PubMed ID: 6350165
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of lymphocyte mitogenesis by asparaginase: a still unexplained phenomenon.
Kafkewitz D; Bendich A
Experientia; 1984 Nov; 40(11):1173-7. PubMed ID: 6389170
[No Abstract] [Full Text] [Related]
4. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
Holcenberg JS; Tang E; Dolowy WC
Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
[TBL] [Abstract][Full Text] [Related]
5. Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice.
Bendich A; Kafkewitz D; Abuchowski A; Davis FF
Clin Exp Immunol; 1982 Apr; 48(1):273-8. PubMed ID: 7044632
[TBL] [Abstract][Full Text] [Related]
6. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
Abuchowski A; van Es T; Palczuk NC; McCoy JR; Davis FF
Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
Avramis VI; Panosyan EH
Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
[TBL] [Abstract][Full Text] [Related]
8. Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase.
Reinert RB; Oberle LM; Wek SA; Bunpo P; Wang XP; Mileva I; Goodwin LO; Aldrich CJ; Durden DL; McNurlan MA; Wek RC; Anthony TG
J Biol Chem; 2006 Oct; 281(42):31222-33. PubMed ID: 16931516
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the effects of asparaginase from Escherichia coli and a glutaminase-free asparaginase from Vibrio succinogenes on specific ell-mediated cytotoxicity.
Durden DL; Distasio JA
Int J Cancer; 1981 Jan; 27(1):59-65. PubMed ID: 7019106
[No Abstract] [Full Text] [Related]
10. L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review.
Sindhu R; Manonmani HK
Anticancer Agents Med Chem; 2022; 22(13):2393-2410. PubMed ID: 34994334
[TBL] [Abstract][Full Text] [Related]
11. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
[TBL] [Abstract][Full Text] [Related]
12. Studies on the glutaminase activity of E. coli asparaginase in tissue culture.
Oerkermann H; Hirschmann WD; Gross R
Recent Results Cancer Res; 1970; 33():125-30. PubMed ID: 4949157
[No Abstract] [Full Text] [Related]
13. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
Ln R; Doble M; Rekha VP; Pulicherla KK
J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase.
Wu MC; Arimura GK; Yunis AA
Int J Cancer; 1978 Dec; 22(6):728-33. PubMed ID: 363626
[TBL] [Abstract][Full Text] [Related]
15. Amino acid utilisation and deamination of glutamine and asparagine by Helicobacter pylori.
Stark RM; Suleiman MS; Hassan IJ; Greenman J; Millar MR
J Med Microbiol; 1997 Sep; 46(9):793-800. PubMed ID: 9291892
[TBL] [Abstract][Full Text] [Related]
16. [Asparaginase and glutaminase activity in Pseudomonas fluorescens in continuous cultivation].
Eremenko VV; Zhukov AV; Nikolaev AIa
Mikrobiologiia; 1975; 44(4):615-20. PubMed ID: 809640
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties and circulating life of Achromobacter glutaminase-asparaginase covalently attached to polyethylene glycol in man.
Abuchowski A; Davis FF; Davis S
Cancer Treat Rep; 1981; 65(11-12):1077-81. PubMed ID: 7296553
[TBL] [Abstract][Full Text] [Related]
18. Asparaginase in the treatment of non-ALL hematologic malignancies.
Emadi A; Zokaee H; Sausville EA
Cancer Chemother Pharmacol; 2014 May; 73(5):875-83. PubMed ID: 24515335
[TBL] [Abstract][Full Text] [Related]
19. Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity.
Distasio JA; Salazar AM; Nadji M; Durden DL
Int J Cancer; 1982 Sep; 30(3):343-7. PubMed ID: 6752048
[No Abstract] [Full Text] [Related]
20. Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes.
Durden DL; Distasio JA
Cancer Res; 1980 Apr; 40(4):1125-9. PubMed ID: 6986981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
